NCT06638931 2026-04-15ANTARESInstituto do Cancer do Estado de São PauloPhase 2 Recruiting28 enrolled
NCT07262970 2025-12-04Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a TumorRezoluteAvailable
NCT02943733 2022-09-23Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETsUniversity of Wisconsin, MadisonPhase 1 Terminated18 enrolled
NCT02402062 2020-07-27A Study to Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pancreatic TumoursGrupo Espanol de Tumores NeuroendocrinosPhase 2 Completed17 enrolled 55 charts